The finding centres on a behaviour called cell traversal. When an infected mosquito bites a host, it injects sporozoites, the parasite’s liver-infective stage, into the skin. These slender, motile parasites enter the bloodstream and travel to the liver, where they must cross the sinusoidal barrier to reach their target hepatocytes. Before doing so, they repeatedly breach the membranes of host cells, glide through the cytoplasm and exit without establishing a lasting infection. This process, first described more than two decades ago, has long been viewed mainly as a mechanical necessity for the parasite’s journey. The new work shows it is also a powerful immunological event, one that shapes the composition and potency of the T cell response that whole-sporozoite vaccines depend upon.

Whole-sporozoite vaccines, which use radiation-attenuated, genetically attenuated or chemically attenuated parasites, are the only malaria vaccine strategy that has consistently achieved sterile protection—the complete prevention of infection—in both rodent models and human trials. This stands in sharp contrast to the licensed subunit vaccines RTS,S and R21, which target the circumsporozoite protein and reduce clinical disease but do not reliably stop infection, a key requirement for eradication. The prevailing assumption has been that whole-sporozoite protection depends primarily on the immunizing parasites infecting hepatocytes and undergoing prolonged intrahepatic development, thereby exposing the host to a broad repertoire of parasite antigens. The Lisbon team set out to test whether that assumption told the whole story.

To do so, the researchers compared wild-type Plasmodium berghei parasites with genetically engineered lines unable to perform cell traversal. One line lacked the SPECT1 protein, a sporozoite microneme component essential for breaching host cell membranes; a second, newly generated line lacked the perforin-like protein PLP1, which serves a similar function. Because traversal-deficient parasites are also less infectious, the team carefully calibrated inoculum sizes, establishing that a fifteen-fold higher dose of the mutant parasites produced liver infection loads equivalent to those achieved with the standard dose of wild-type parasites. Crucially, the mutants retained normal gliding motility and, once inside hepatocytes, developed normally, meaning any difference in vaccine efficacy could be attributed specifically to the loss of traversal rather than to a general defect in parasite fitness.

The results were striking. In a standard prime–boost–boost immunization regimen with radiation-attenuated sporozoites, roughly 82.5 percent of mice vaccinated with wild-type parasites were completely protected against subsequent challenge with infectious parasites, showing no blood-stage infection over a twelve-day monitoring period. Among mice vaccinated with the traversal-deficient parasites, however, protection collapsed: none of the SPECT1-deficient cohort and only about 13 percent of the PLP1-deficient cohort remained parasite-free. The pattern held even under immunization regimens that allowed extended or complete intrahepatic development, using infectious sporozoites under azithromycin or chloroquine chemoprophylaxis. Even when the mutant parasites replicated fully in the liver, they failed to confer sterilizing immunity. Conversely, parasites lacking the P36p protein—which cannot develop substantially in the liver but retain full traversal ability—protected mice just as effectively as wild-type parasites, with comparable durability over nearly seven months.

These findings decouple protection from productive intrahepatic development and reposition parasite behaviour as a central immunogenic determinant. But what mechanism underlies this effect? The team found that antibody responses were largely intact in mice vaccinated with traversal-deficient parasites: anti-sporozoite IgG levels rose comparably in all immunized groups, regardless of the parasites’ ability to traverse cells or develop in the liver. The deficit lay specifically in cellular immunity. In C57BL/6 mice, a strain in which protection depends on CD8 T cells clearing infected hepatocytes, traversal-deficient vaccination failed to generate the protective T cell response. When the researchers depleted CD8 T cells from wild-type-vaccinated C57BL/6 mice before challenge, protection vanished entirely, confirming the dominant role of these cells. In BALB/c mice, a strain that mounts strong antibody-mediated responses, both wild-type and traversal-deficient parasites conferred full protection, and CD8 T cell depletion had no effect—demonstrating that traversal matters precisely when protection relies on T cells.

Using high-parameter spectral flow cytometry and unsupervised clustering of liver leukocytes, the researchers then identified the specific cell population affected. Mice vaccinated with traversal-competent parasites showed a marked expansion of CD8 tissue-resident memory T cells, or TRM cells, in the liver—cells bearing the hallmark markers CD69 and KLRG1-negative status, along with high CXCR3 and CXCR6 expression and elevated CD127 and PD-1, consistent with long-lived, antigen-experienced residents. These cells were significantly under-represented in mice vaccinated with traversal-deficient parasites. Liver-resident memory CD8 T cells are known to form a front-line defence against malaria liver-stage infection, and their presence correlates with durable protection. The team also found that these cells persisted in the liver at least seventy-five days after priming, matching the window of robust protection observed in challenge experiments.

Delving deeper into antigen specificity, the researchers examined CD8 TRM cells targeting two well-characterized Plasmodium epitopes: PbTRAP, a thrombospondin-related protein expressed mainly at the sporozoite stage and shed during parasite locomotion, and PbRPL6, a ribosomal protein associated with intrahepatic development. Vaccination with traversal-competent parasites expanded TRM cells specific for both epitopes. Traversal-deficient vaccination, however, selectively compromised the TRAP-specific population while leaving RPL6-specific cells detectable, albeit reduced. This selective loss suggests that traversal amplifies responses against sporozoite-derived antigens in particular, plausibly by disseminating parasite material across many host cells early in infection. Notably, the defect was not explained by reduced TRAP shedding during gliding motility, and splenectomy experiments showed that while splenic priming contributes to the overall magnitude of the hepatic TRM pool, traversal at the site of infection independently shapes its antigen-specific composition.

The implications for vaccine design are substantial. Current efforts have focused overwhelmingly on identifying optimal antigens and epitopes; this study argues that the dynamic interactions between the parasite and host tissues deserve equal attention. Next-generation whole-sporozoite vaccines might be engineered or selected for enhanced traversal motility to promote stronger, longer-lasting liver-resident CD8 TRM responses. Alternatively, the molecular and inflammatory cues generated by cell traversal could inspire adjuvants that mimic its immunostimulatory effects, potentially benefiting subunit vaccines that currently rely on humoral immunity alone. The findings may also help explain why responses to whole-sporozoite vaccines in humans are heterogeneous, with some vaccinees failing to achieve sterile protection for reasons that remain poorly understood.

There is also an evolutionary dimension worth pondering. It may seem paradoxical that a parasite evolved a behaviour that ultimately arms the immune system against it. The authors suggest this represents a trade-off: under natural transmission, only a small number of sporozoites reach the liver, and traversal is essential for crossing the skin and sinusoidal barriers to establish infection at all. The immunostimulatory consequences only become decisive during vaccination, when artificially high parasite doses amplify exposure to traversal-dependent cues. Whether this principle—harnessing parasite behaviour rather than merely parasite antigens—can be translated into human vaccines remains an open question, particularly since liver-resident T cells are difficult to sample directly in people. Still, the study marks a conceptual shift: for malaria, how a parasite moves through its host may matter as much as what it is made of.

Subject of Research: The role of Plasmodium sporozoite host cell traversal in inducing sterilizing CD8 T cell-mediated immunity after whole-sporozoite malaria vaccination

Article Title: Host cell traversal by Plasmodium parasites drives sterilizing T cell-mediated immunity following immunization

Article References: Rodrigues, A., Mendes, A. M., Gonçalves, R., Nunes-Cabaço, H., Marques, S., Valente-Leal, N., Gomes da Costa, D., Ferreira, C., Veldhoen, M., Prudêncio, M., Mota, M. M., & Chora, Â. F. (2026). Host cell traversal by Plasmodium parasites drives sterilizing T cell-mediated immunity following immunization. Nature Microbiology. https://doi.org/10.1038/s41564-026-02477-2

Image Credits: AI Generated

DOI: 10.1038/s41564-026-02477-2

Keywords: malaria, Plasmodium, sporozoites, cell traversal, T cells, tissue-resident memory T cells, vaccines, liver-stage immunity, CD8 T cells, radiation-attenuated sporozoites, immunology, Nature Microbiology

The research, published in Nature Microbiology by a team led by scientists at the University of Utah Health, the University of Douala, and the Centre Pasteur du Cameroun, combined large-scale genetic analysis of human blood samples with equally detailed sequencing of the malaria parasites infecting them. Working in Mfou, a malaria-endemic community in Cameroon, the researchers analyzed genetic material from more than 2,000 people, capturing both symptomatic infections and the far more numerous asymptomatic ones. What emerged was a picture of host-pathogen interaction far more intricate than the conventional narrative of a human mutation simply blocking parasite growth inside red blood cells.

The central discovery is striking: people who carry the sickle cell variant are almost exclusively infected by a genetically distinct variety of malaria parasites. In other words, the parasite population infecting a person is not random with respect to their hemoglobin genotype. Parasites with one genetic signature dominate infections in carriers of the sickle cell trait, while parasites with a different genetic makeup are more commonly found in people without the variant. This pattern held not only in the rare cases where carriers fall ill, but also — and crucially — in the vast pool of asymptomatic infections that make up most malaria transmission in endemic settings.

Asymptomatic infections are the quiet majority of the malaria burden. In the Mfou study population, roughly three-quarters of apparently healthy participants carried malaria parasites in their blood without showing any symptoms. These silent reservoirs are less visible to clinics and surveillance systems than the fevers and hospitalizations of clinical malaria, but they sustain transmission and represent the environment in which the parasite and its human host negotiate their long evolutionary standoff. By extending their analysis to this hidden majority, the researchers uncovered a relationship that earlier work focused on symptomatic disease could not fully reveal.

Perhaps the most consequential finding concerns infection rates versus disease rates. People carrying the sickle cell variant become infected with malaria parasites at roughly the same overall frequency as people without the variant — they simply tend to harbor a different genetic variety of the parasite. Yet carriers are about ten times less likely to develop harmful, symptomatic disease. This observation upends a tempting earlier hypothesis. When the distinct parasite strain was first identified in symptomatic carriers of the sickle cell trait, scientists speculated that it might be a kind of superbug, unusually adept at breaking through the carriers’ defenses and causing illness. The new data suggest nearly the opposite: the biological properties of this parasite variety may themselves contribute to the carriers’ protection, rather than undermining it.

That reframing matters because it changes where researchers should look for answers. The classical explanation for sickle cell trait protection centers on the human host: the altered hemoglobin environment inside red blood cells is thought to stress the parasite, shorten the lifespan of infected cells, and impair the parasite’s ability to replicate and to cause the sequestration in small blood vessels that underlies severe disease. The new findings do not overturn that biology, but they add a second dimension. If the parasites capable of establishing infection in sickle cell trait carriers are systematically different from those infecting other people, then part of the protective effect may lie in the parasite’s own characteristics — how virulent it is, how efficiently it multiplies, or how readily it triggers the inflammatory cascades that produce symptoms.

Sandrine Nsango, associate professor of molecular biology at the University of Douala, researcher at the Centre Pasteur du Cameroun, and one of the senior authors of the study, framed the result as evidence of a two-way evolutionary conversation. The sickle cell mutation, she noted, is one of the clearest examples of how an infectious disease can shape human evolution, but the findings suggest that humans also shape the evolution of the parasite in return. The parasite lineages that can survive in the red blood cells of trait carriers are, in effect, a selected subset of the parasite population — filtered by generations of host genetics. Understanding that filtering process, she argued, may help scientists anticipate how malaria parasites adapt in the future and design more effective strategies for malaria control.

Ellen Leffler, assistant professor of human genetics at University of Utah Health and the study’s other senior author, described the discovery as something that had been hiding in plain sight. Researchers have studied the association between sickle cell trait and malaria protection for more than half a century, but the parasite’s side of the story required tools that only became practical recently: high-throughput DNA sequencing capable of characterizing whole parasite populations directly from human blood samples. As Leffler put it, people have been examining this association for a long time, but you have to be able to ask the parasite for it to tell you this. The new sequencing approach effectively did exactly that, revealing that the genotype of the infecting parasite is a variable that previous study designs largely ignored.

The implications extend beyond evolutionary theory into practical medicine and public health. If specific parasite genotypes are associated with asymptomatic carriage in sickle cell trait carriers, then parasite genetics could become a tool for tracking transmission, identifying which parasite lineages circulate in a community, and monitoring how the parasite population shifts under the pressure of interventions such as bed nets, drugs, and vaccines. Leffler emphasized that the work opens a new dimension for understanding what determines the outcome of an infection, and expressed hope that it will lead to a deeper biological understanding of the parasite and of this co-evolutionary system — one she described as quite unique in humans — and ideally to practical new strategies for tracking or treating infections.

The study also serves as a reminder of how much remains unknown about one of biology’s most famous examples of natural selection. The sickle cell allele’s protective effect was first proposed in the 1950s and has since become a textbook staple, yet the full mechanism has never been a single tidy story. Red blood cell physiology, immune responses, and parasite biology all appear to contribute, and disentangling them requires studying real populations in endemic regions, where people are repeatedly exposed to genetically diverse parasites over a lifetime. The Mfou cohort, sequenced at the level of both human and parasite genomes, offers exactly that kind of window. The work was supported by the Fondation Pierre Fabre under the IMPAS project and by the American Heart Association, and the authors report no competing interests. As malaria control efforts worldwide confront drug resistance and shifting parasite populations, the message of this study is clear: to understand why some people are protected, scientists must listen not only to the human genome but to the parasite’s as well.

Subject of Research: How sickle cell haemoglobin status shapes the genotypes of malaria parasites in asymptomatic human infections

Article Title: Distinct malaria parasites “hidden in plain sight” may contribute to human disease protection

Article References: Distinct malaria parasites “hidden in plain sight” may contribute to human disease protection. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: malaria, sickle cell trait, Plasmodium, hemoglobin, genomics, asymptomatic infection, coevolution, Cameroon, parasite genetics, Nature Microbiology, human evolution, disease protection

Avian haemosporidians are a group of apicomplexan parasites belonging chiefly to three genera: Plasmodium, Haemoproteus, and Leucocytozoon. In birds, these organisms can behave much like the malaria parasites that afflict humans, invading blood cells and internal organs, sapping host condition, and in severe cases reducing survival and reproductive success. Their effects ripple outward into population dynamics, migration behavior, and even the structure of whole bird communities. For decades, ecologists have worked to map which insect vectors carry which parasite lineages, because transmission is the hinge on which the entire host-parasite system turns. Mosquitoes, Culicoides biting midges, louse flies, and black flies are the recognized vectors, each genus of parasite showing affinities for particular insect groups and particular bird hosts.

Leptoconops is a genus of haematophagous biting midges in the family Ceratopogonidae, closely related to the better-known Culicoides midges that are established vectors of avian Haemoproteus. Despite this kinship, Leptoconops midges have never been systematically implicated in avian malaria transmission, and no previous study had molecularly screened them for haemosporidian infections. That gap is precisely what motivated the research team, led by Javier Carbonero and Martina Ferraguti of the Estación Biológica de Doñana, a research institute of the Spanish National Research Council (CSIC) in Seville, together with colleagues affiliated with the Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública.

The scale of the fieldwork reflects the difficulty of the question. During 2024, the researchers collected a total of 5,417 female Leptoconops midges across sites in Andalusia, taking advantage of the fact that only female midges take blood meals and can therefore plausibly acquire and transmit blood parasites. Each specimen was morphologically identified to species, a labor-intensive step that matters because vector competence and host preferences can differ sharply even between close relatives. The midges were then grouped into 203 pools for molecular analysis, a pooling strategy that balances laboratory workload against the sensitivity needed to detect low-level infections in wild-caught insects.

The molecular heart of the study is a nested polymerase chain reaction (PCR) protocol targeting the cytochrome b gene, the standard DNA barcode region for avian haemosporidians. Nested PCR uses two successive rounds of amplification with two pairs of primers, dramatically increasing sensitivity and allowing researchers to detect the minute quantities of parasite DNA that may persist in an insect after a blood meal has been digested. Positive amplicons were then sequenced, and the resulting DNA barcodes were compared against reference databases to assign each parasite to a genus and, where possible, to a known lineage with a documented host range. This lineage-level resolution is what gives the study its ecological punch: many haemosporidian lineages have been catalogued from specific bird species, so finding a lineage inside a midge hints at which birds the midge may have bitten.

Eight of the 203 pools tested positive for haemosporidian DNA. The positive pools corresponded to two of the Leptoconops species examined, Leptoconops communis and Leptoconops nigrithorax, indicating that more than one member of the genus encounters these parasites in the wild. The identified parasites spanned all three target genera. Among the Haemoproteus detections were Haemoproteus noctuae, corresponding to the lineage CIRCUM01, and an unidentified Haemoproteus species of the lineage COLPAL01. The Plasmodium findings included Plasmodium matutinum, the well-characterized lineage LINN1, while Leucocytozoon was represented by the lineages COLIV04 and AEMO02. In addition to these known barcodes, the team uncovered two lineages that had never been recorded before, which they designated Plasmodium P_LEPTO01 and Haemoproteus H_LEPTO01, expanding the global catalogue of avian haemosporidian genetic diversity.

The known host associations of the detected lineages are where the story becomes genuinely suggestive. Haemoproteus noctuae, for example, is a parasite associated with owls and other birds, and lineages such as LINN1 and COLIV04 have been documented from particular avian hosts in previous surveys. By matching the lineages found in the midges to their known bird hosts, the researchers can infer, indirectly, which avian species Leptoconops midges may have fed upon. This approach, sometimes framed within the broader use of insect-derived DNA as a sampling tool, effectively turns each infected midge into a tiny record of both a bird-parasite interaction and a midge feeding choice. It is an indirect inference rather than a direct blood-meal identification, but it provides testable hypotheses about the feeding ecology of a genus whose biting habits remain poorly documented in many regions.

The authors are careful, and appropriately so, about what the results do and do not demonstrate. Detecting parasite DNA in an insect does not establish vector competence, the ability of a vector to support the parasite’s full developmental cycle and transmit it to a new host. Haemosporidian parasites undergo a complex development within a competent vector, including sexual reproduction, invasion of the insect’s gut wall, production of infective sporozoites, and migration to the salivary glands. Parasite DNA could, in principle, simply reflect the digestion of an infected blood meal without any subsequent parasite development. The researchers explicitly state that vector competence has not been demonstrated and that the potential role of Leptoconops in transmission is unknown and merits further investigation. Disentangling genuine biological transmission from mere mechanical carriage of DNA will require experimental infection studies, dissection of midge tissues, and detection of parasite developmental stages rather than DNA alone.

Even with those caveats, the study carries weight for several reasons. First, it establishes a previously unrecorded interaction between a widespread genus of biting midges and avian haemosporidian parasites, adding Leptoconops to the short list of insect groups in which these parasites have been molecularly detected. Second, the diversity of parasites found, spanning Plasmodium, Haemoproteus, and Leucocytozoon, suggests that the encounters are not a rare accident of a single parasite species but a broader pattern involving multiple parasite lineages and at least two midge species. Third, the discovery of two novel lineages underscores how much undocumented parasite diversity circulates in wild bird communities and their vectors, and how vector-focused sampling can surface it. Fourth, the work has practical implications: if Leptoconops midges prove to be competent vectors, current models of avian malaria transmission, which lean heavily on mosquitoes and Culicoides, would need revision, with consequences for understanding disease dynamics in bird populations, the risks faced by vulnerable species, and even the epidemiology of zoonotic or wildlife pathogens in shared landscapes.

The research was conducted by a team based at the Estación Biológica de Doñana in Seville, with funding from projects including ARBOPREVENT, supported by Fundación La Caixa, a national research project financed by Spain’s Ministry of Science and European regional funds, and the Severo Ochoa excellence program. The work formed part of a broader research effort on vector ecology in southern Spain, where wetland habitats concentrate both bird diversity and biting insects. As the authors conclude, the findings suggest real interactions between Leptoconops midges and infected avian hosts, and they call for further studies to determine whether these midges are incidental carriers or genuine players in the transmission of avian malaria. For now, a genus of tiny midges, long noted mainly for the irritating bites of its females, has earned a place on the watch list of avian disease ecology, and the search for its true role in the parasite’s life cycle is only beginning.

Subject of Research: Molecular detection of avian haemosporidian parasites in Leptoconops biting midges

Article Title: First molecular detection of avian haemosporidian parasites in Leptoconops (Diptera: Ceratopogonidae) biting midges

Article References: Carbonero, J., González, M. A., Magallanes, S., Paun-Tanase, D. I., Martínez-de la Puente, J., Figuerola, J., & Ferraguti, M. (2026). First molecular detection of avian haemosporidian parasites in Leptoconops (Diptera: Ceratopogonidae) biting midges. Parasites & Vectors. https://doi.org/10.1186/s13071-026-07713-6

Image Credits: AI Generated

DOI: 10.1186/s13071-026-07713-6

Keywords: avian malaria, haemosporidian parasites, Leptoconops, biting midges, Ceratopogonidae, Plasmodium, Haemoproteus, Leucocytozoon, vector ecology, cytochrome b, nested PCR, Andalusia

Single-cell RNA sequencing, or scRNA-seq, does something deceptively simple: instead of measuring the collective gene activity of an entire tissue, it profiles the transcriptome of individual cells. The transcriptome, the complete set of RNA molecules in a cell, acts as the bridge between the static genome and dynamic biological function. Bulk transcriptomics blurs this picture, masking the heterogeneity of the many cell types that make up even a small organ such as a mosquito midgut. By deconstructing tissues into their constituent cells, scRNA-seq allows researchers to discover rare cell populations, reconstruct developmental trajectories and map communication networks between cells. The technology has already driven breakthroughs in oncology, neuroscience and virology, and the review’s authors, led by Li-Bo Liu and Jia-Hong Wu of Guizhou Medical University, contend that mosquitoes are its next great frontier.

The technical pipeline is demanding at every step. Researchers must dissect tissues or collect hemolymph, isolate single cells or nuclei, capture them, prepare sequencing libraries and run high-throughput sequencing before any computational analysis begins. Each choice carries biological consequences. Enzymatic dissociation can stress cells and induce artificial transcriptional responses, and fragile or large cell types may be selectively lost. For tissues that resist dissociation, such as the brain or fat body, single-nucleus RNA sequencing offers an alternative that preserves cell-type proportions, though at the cost of losing cytoplasmic transcripts. The incorporation of unique molecular identifiers allows digital counting of original transcripts and mitigates amplification bias, while the choice between plate-based methods such as Smart-seq2, which deliver near-complete transcript coverage of relatively few cells, and droplet-based systems such as 10x Genomics Chromium, which profile tens of thousands of cells at shallower depth, fundamentally shapes what can be observed.

These trade-offs are not abstract. In studies of the malaria mosquito Anopheles gambiae, the high throughput of 10x Chromium succeeded in capturing megacytes, a rare hemocyte subpopulation making up only about 0.5 percent of immune cells, whereas Smart-seq2’s superior sensitivity identified phagocytic granulocytes that the droplet platform missed. Both findings were validated by in situ hybridization, confirming that the discrepancies stemmed from technical characteristics rather than false positives. The review’s authors emphasize that such variation demands rigorous reporting standards, including adherence to emerging minimum-information guidelines for single-cell experiments, explicit documentation of platforms and computational parameters, and independent validation of novel cell types before they are accepted as biological reality rather than computational artifacts.

What has the technology actually revealed? Perhaps the most striking lesson is that classical cell classifications were far too coarse. Mosquito hemocytes, the insect immune cells, were traditionally divided into granulocytes, oenocytoids and prohemocytes. Single-cell profiling has exploded this scheme into a multilevel system, showing that granulocytes comprise conventional, proliferative, antimicrobial and phagocytic subtypes, alongside megacytes that appear to coordinate immune responses mediated by hemocyte differentiation factor. Intriguingly, megacytes were not detected in Aedes aegypti, suggesting genuinely distinct immune lineages among vector species rather than a technical artifact, and challenging the assumption of a universal insect immune cell blueprint. The midgut epithelium has undergone a similar refinement: enterocytes once treated as a uniform class now resolve into five subtypes enriched for distinct digestive enzymes or immune factors, while enteroendocrine cells split into three subtypes specializing in different neuropeptide signals.

ScRNA-seq has also uncovered cell populations that fit no existing category. In the fat body of blood-fed Aedes aegypti, researchers identified fat-body-yolk cells, which coexpress markers of metabolic fat body tissue, ovarian reproductive tissue, stem cell genes and even eggshell formation genes. Their persistence after a blood meal, even when no oviposition sites are available, hints at a poised state dedicated to maintaining reproductive readiness, a possible adaptation to unpredictable breeding opportunities. The authors caution, however, that transcriptional identity does not equal validated function; the hypothesized roles of these cells in lipid transport, resource reallocation and defense remain compelling but untested. Cell atlases have now been extended to salivary glands, testes and the nervous system, laying groundwork for a comprehensive reference that could inform next-generation insecticides, gene-drive strategies and transmission-blocking interventions.

The technology’s power to dissect dynamic physiology is vividly illustrated by the response to a blood meal, the event that makes mosquitoes dangerous. Within one day of feeding, three nascent enterocyte clusters surged from 0.4 percent to 52.2 percent of midgut cells, an expansion too rapid for new cell generation and one that points to transdifferentiation of existing cells, though the origin remains unresolved. In the fat body, trophocyte proportions shifted between two and seven days post-feeding, with upregulation of trehalose synthesis genes and immune regulators coupling metabolic reprogramming to immune activation. Hemocyte numbers doubled by day seven, and even the brain participated: single-nucleus sequencing revealed dramatic transcriptional changes in glial cells within three hours of feeding, including upregulation of steroid hormone receptors and circadian clock genes, implicating glia as regulators of the post-blood-meal behavioral switch.

Sexual dimorphism, too, has acquired a cellular basis. Female Aedes aegypti brains are enriched for specific Kenyon cells, dopaminergic neurons and projection neurons, while male brains contain higher proportions of particular glial cells and other neuronal classes. Sex-biased gene expression follows, with males showing higher expression of the sex determination factor Nix and females expressing dipeptidyl peptidases at elevated levels. Notably, the sex determination gene doublesex is more highly expressed in glial cells than in neurons, suggesting an underappreciated role for glia in establishing sexual identity. In sensory organs, male-specific epithelial-like cells in antennae and female-specific neurons in the proboscis provide cellular correlates for sex-specific behaviors such as host-seeking. Single-nucleus data have likewise challenged the one neuron–one receptor dogma of sensory coding, revealing frequent coexpression of odorant and ionotropic receptors, and coexpression of taste and temperature sensors in gustatory neurons, expanding the theoretical coding capacity of the mosquito nervous system.

The most consequential applications may lie in host–pathogen interactions. Conventional scRNA-seq pipelines discard non-host reads as contamination, but adapted protocols, notably 5′ capture methods compatible with microfluidic platforms, can capture viral RNAs that lack polyadenylated tails. Using such approaches, researchers found that Zika virus preferentially targets enteroendocrine cells and enterocytes in the Aedes aegypti midgut, while West Nile virus reaches its highest loads in enteroendocrine cells of Culex tarsalis, hinting at a conserved flaviviral susceptibility tied to these cells’ signaling and secretory functions. In Anopheles gambiae, dual host–parasite sequencing showed that Plasmodium ookinetes preferentially interact with midgut progenitor cells during epithelial traversal, an interaction conserved across Anopheles species and parasite isolates. Immune responses are equally illuminating: enterocytes infected with Zika express antimicrobial peptides, whereas West Nile virus infection in Culex tarsalis produced no broad tissue-level immune activation, a finding that challenges the midgut’s reputation as a key site of innate immune defense and may partly explain that species’ vector competence.

These discoveries are already generating testable intervention targets. The enrichment of apolipophorin III in Zika-infected enteroendocrine cells led to RNA interference experiments confirming that this lipid transport protein supports viral replication, marking it as a candidate target. Similarly, single-cell analysis identified the LL3 gene as highly expressed in megacytes and essential for the hemocyte differentiation factor-mediated anti-Plasmodium response, establishing a rare cell type as a critical regulatory node in malaria vector immunity. The review’s authors are candid about remaining obstacles: cell annotation still leans heavily on Drosophila orthology, atlases remain incomplete for organs such as ovaries and compound eyes, and most findings await functional validation. The path forward, they argue, lies in integrating spatial transcriptomics, single-cell multiomics and perturbation-based experiments to build predictive models of mosquito–pathogen interactions. If that integration succeeds, single-cell insights accumulated over the past several years could mature from a discovery engine into the foundation of a new generation of targeted vector control strategies.

Subject of Research: Application of single-cell RNA sequencing to mosquito biology and mosquito–pathogen interactions

Article Title: Single-cell RNA sequencing unravels mosquito biology and host–pathogen interactions

Article References: Liu, L.-B., Ye, H.-B., Tian, Z.-H., Zeng, X.-H., & Wu, J.-H. (2026). Single-cell RNA sequencing unravels mosquito biology and host–pathogen interactions. Parasites & Vectors, 19(1), Article 426. https://doi.org/10.1186/s13071-026-07460-8

Image Credits: AI Generated

DOI: 10.1186/s13071-026-07460-8

Keywords: single-cell RNA sequencing, mosquito, vector biology, host–pathogen interactions, cell atlas, Zika virus, West Nile virus, Plasmodium, malaria, dengue, vector control, transcriptomics

Attenuated sporozoites, the infective stage of Plasmodium parasites injected by mosquitoes, have been tested as vaccines for decades because they provoke robust adaptive immunity that protects against subsequent challenge. The most advanced of these approaches, whole-sporozoite vaccines designed to protect through hepatic CD8 T cell immunity, have shown encouraging results in clinical trials. Yet a fundamental question has lingered: how do these parasites engage the innate immune system to license such potent T cell responses? Pattern recognition receptors such as Toll-like receptors and inflammasome sensors are the canonical gatekeepers of innate immunity, but their role in sporozoite immunogenicity has never been clearly defined.

To answer this, the team built what they describe as a reductionist system. They generated fluorescent GFP-expressing Plasmodium berghei and Plasmodium falciparum sporozoites, purified the parasites by flow cytometry directly from mosquito salivary glands, and sorted them onto mouse bone marrow-derived macrophages or human peripheral blood mononuclear cells. This allowed them to isolate the innate response to sporozoites from the confounding signals of mosquito saliva, blood-stage parasites, and other contaminants that complicate whole-organism studies. They then profiled the responding cells using bulk and single-cell RNA sequencing, capturing the transcriptional landscape of innate activation at high resolution.

The results were striking. Sporozoites did not induce the classical inflammatory programs associated with microbial pattern recognition. Instead, the transcriptional signature in macrophages and human monocytes resembled a cell wounding response, the program that cells mount when their plasma membrane is breached. This makes biological sense: sporozoites must traverse host cells as they migrate from the skin through the dermis to the liver, breaching the membranes of the cells they pass through before finally settling in hepatocytes. The parasites, in effect, leave a trail of wounded cells, and the immune system reads that trail as a danger signal.

The evidence for this interpretation came from a decisive genetic experiment. The researchers used sporozoites lacking SPECT1, a protein with a membrane attack complex-like domain that is essential for pore formation and cell traversal. These traversal-deficient parasites, which can still invade hepatocytes but cannot punch through intermediate cells, failed to activate bone marrow-derived macrophages in vitro. The wounding signature disappeared entirely when the pore-forming machinery was removed, demonstrating that the innate activation was not triggered by parasite molecules detected by conventional sensors but by the physical damage the parasite inflicts on host cells.

Importantly, the wounding response was independent of both inflammasome and Toll-like receptor signalling, the two most intensively studied pathways of innate immune activation. This rules out the standard explanation and points instead toward a distinct sensing modality. Previous work from other laboratories has shown that cells surviving sublethal plasma membrane injury mount a characteristic transcriptional response involving repair machinery and chemokine production, and the sporozoite-induced signature overlapped with these curated plasma membrane injury gene sets. The immune system, it appears, can detect the wound itself rather than the weapon that caused it.

The study then connected this innate sensing to the adaptive immunity that actually protects against malaria. In mice immunized with traversal-deficient irradiated sporozoites, the priming of protective CD8 T cell responses was markedly impaired compared with immunization using normal traversal-competent parasites. Given that CD8 T cells are the critical mediators of sterile immunity against the liver stage of malaria, this deficit is not a minor detail. It suggests that the wounding of host cells during traversal is not incidental damage but an essential adjuvant-like signal that the whole-sporozoite vaccine platform depends upon.

A further layer of the mechanism involves γδ T cells, an unconventional lymphocyte population that bridges innate and adaptive immunity. The researchers found that the sensing of cell traversal required γδ T cells, which are already known to support CD8 T cell responses against Plasmodium. Earlier work has shown that γδ T cells are required for the induction of sterile immunity during irradiated sporozoite vaccination, and recent studies have demonstrated that γδ T cell-derived IL-4 can initiate CD8 T cell immunity. The new findings place these cells squarely within the sensing pathway: they appear to translate the cell wounding signal into help for the CD8 T cells that will later eliminate infected hepatocytes.

The cross-species consistency of the results strengthens their significance. Human monocytes exposed to Plasmodium falciparum sporozoites showed an activation pattern that overlapped with the mouse data, including the plasma membrane injury signature, indicating that the mechanism is not a rodent-specific curiosity but likely operates in human malaria infection and vaccination. Single-cell RNA sequencing of human peripheral blood mononuclear cells revealed that multiple innate cell types respond to sporozoites, with the response distinguishable from that induced by blood-stage parasites, which instead triggered more conventional inflammatory programs.

For vaccine development, the implications are considerable. Subunit vaccines based on the circumsporozoite protein have struggled to achieve the high levels of protection seen with whole sporozoites, and this study offers a possible explanation: they lack the cell traversal signal that recruits γδ T cells and licenses potent CD8 T cell priming. Incorporating a wounding-mimetic adjuvant, or designing vaccine delivery strategies that reproduce the membrane injury signal, could help close that gap. Conversely, the findings caution that any attenuated sporozoite vaccine engineered to block traversal, however attractive from a safety standpoint, might sacrifice immunogenicity. As malaria continues to claim hundreds of thousands of lives each year, understanding why live sporozoites are such effective teachers of the immune system brings the field one step closer to a vaccine that can match that performance without a live parasite.

Subject of Research: Innate immune sensing of Plasmodium sporozoite cell traversal and its role in priming protective CD8 T cell responses

Article Title: Innate immune sensing of Plasmodium sporozoite cell traversal drives protective T cell responses

Article References: Pohl, K. G., Gao, X., McGowan, J., Mukherjee, P., Le, S., Carreira, P., Ngo, C., Sutton, H. J., Brumhard, S., Hiller, A., Kelly, H. G., Liow, L., Lo, A., Henze, L., Loyal, L., Amino, R., Man, S. M., Beattie, L., Sander, L. E., & Cockburn, I. A. (2026). Innate immune sensing of Plasmodium sporozoite cell traversal drives protective T cell responses. Nature Microbiology. https://doi.org/10.1038/s41564-026-02460-x

Image Credits: AI Generated

DOI: 10.1038/s41564-026-02460-x

Keywords: malaria, Plasmodium, sporozoites, cell traversal, innate immunity, CD8 T cells, gamma delta T cells, vaccines, plasma membrane injury, Nature Microbiology, immunology, parasitology

The research team began with a systematic question about a large and underexplored molecular family. Ubiquitination, the process by which the small protein ubiquitin is attached to target proteins, governs countless cellular activities in eukaryotes, from protein degradation to DNA repair and cell differentiation. The process requires a cascade of enzymes: E1 activating enzymes priming ubiquitin, E2 conjugating enzymes transferring it, and E3 ligases conferring substrate specificity. While ubiquitination was known to operate in Plasmodium parasites, whether any particular ubiquitination machinery specifically controlled the sexual conversion step was unknown. To find out, the researchers deployed CRISPR–Cas9 mutagenesis screens against the complete repertoire of E2 ubiquitin-conjugating enzyme genes in the rodent malaria parasite Plasmodium yoelii, systematically deleting each of the fourteen E2 genes and assessing the consequences for parasite development across the life cycle.

The screen produced a clear winner. An E2 enzyme the authors designate Rad6B emerged as essential for gametocytogenesis, the process by which asexual blood-stage parasites convert into gametocytes. When Rad6B was deleted, gametocyte production collapsed to severe defects, and the mutant parasites proved dramatically impaired in their ability to form oocysts in the mosquito midgut, the critical developmental stage that follows ingestion of gametocytes during a blood meal. Parasitemia and host survival in mice infected with the Rad6B deletion mutant remained comparable to wild-type infections, indicating that the enzyme’s essential function was not in general blood-stage proliferation but specifically in the developmental switch that enables transmission. Whole genome sequencing and Sanger sequencing confirmed that the observed phenotypes stemmed cleanly from the targeted gene disruptions rather than off-target alterations.

Rad6B did not act alone. Through interaction analyses, the team identified its partner: a RING-type E3 ubiquitin ligase called Tex1. The pairing follows a well-established logic in ubiquitin biology, in which the E2 enzyme carries activated ubiquitin while the RING-domain E3 ligase recognizes the substrate and catalyzes the transfer. Deleting Tex1 phenocopied the loss of Rad6B, producing severe defects in gametocyte production and oocyst formation, and the two proteins were shown to function as a complex. To verify that the enzymatic activities of both partners were required, the researchers engineered point-mutant parasites: a Rad6B variant in which the conserved catalytic cysteine in the ubiquitin-conjugating domain was substituted, and Tex1 variants in which conserved arginine and lysine residues of the RING domain were mutated or the domain deleted outright. In every case, the disruption of catalytic function abolished the pathway’s effect on gametocytogenesis, confirming that genuine ubiquitin transfer—not a scaffolding role—lay behind the phenotype.

The substrate that the Rad6B–Tex1 complex targets turned out to be histone H2B, one of the core proteins around which DNA is wound. The complex catalyzes monoubiquitination of H2B, the attachment of a single ubiquitin molecule to a specific lysine residue on the histone. This modification has an illustrious history in biology: it was first characterized in yeast, where the Rad6 ortholog and its RING partner Bre1 mark H2B, and it was subsequently shown to regulate gene silencing, H3 methylation and differentiation of multipotent stem cells in mammals. The new study demonstrates that the same modification operates in Plasmodium yoelii and, crucially, in Plasmodium falciparum, the parasite responsible for the most deadly form of human malaria. Using ChIP-seq and CUT&Tag-seq, the researchers mapped H2B monoubiquitination across the parasite genome and found it dramatically reduced at specific loci in both the Rad6B and Tex1 deletion mutants.

The mechanistic chain then became clear through a series of elegant chromatin analyses. In wild-type parasites, H2B monoubiquitination at the ap2-g promoter region promotes the occupancy of tri-methylated histone H3 lysine 4, or H3K4me3, an activating histone mark classically associated with open, transcriptionally permissive chromatin. When the Rad6B–Tex1 complex was absent, this H3K4me3 enrichment at the ap2-g promoter was lost, ap2-g expression failed to rise, and the parasites remained locked in the asexual program. CUT&Tag-seq in the deletion mutants showed parallel losses of both H2Bub and H3K4me3 signals at the ap2-g locus, with other chromatin marks such as H3K79me3 and heterochromatin protein 1 distributions assessed for comparison. The effect was spatially specific: other AP2 family transcription factors and regulatory genes, including ap2-g2, ap2-g3, ap2-g5, hda2 and hp1, showed no comparable loss of H2Bub, indicating that the pathway does not broadly remodel the chromatin landscape but instead focuses on the master regulator of sexual commitment.

To prove that the histone mark itself, rather than some other function of Rad6B, was the causal agent, the team performed knock-in experiments that border on molecular surgery. They generated parasite lines in which the endogenous histone H2B was replaced with versions carrying substitutions at the ubiquitination site, and similarly modified H3 at the lysines subject to methylation. Parasites carrying an H2B version that cannot be monoubiquitinated failed to activate ap2-g and could not commit to gametocytogenesis, while restoring the ubiquitin-acceptable residue restored the pathway. Complementary experiments showed that altering the H3 lysine targeted for tri-methylation likewise disrupted sexual commitment, placing H2B monoubiquitination upstream of H3K4me3 in a coherent signaling relay. Transcriptomic comparisons reinforced the picture: genes downregulated in the Rad6B and Tex1 mutants overlapped substantially, and their orthologs in P. falciparum and P. berghei were enriched for genes whose expression peaks during gametocyte development, indicating that the two enzymes converge on the sexual differentiation program.

Perhaps the most consequential finding is the conservation of this mechanism in the human parasite. In Plasmodium falciparum, disruption of either Rad6B or Tex1 produced the same chromatin consequences—loss of H2Bub and H3K4me3 at the ap2-g locus—and the same failure to produce gametocytes, while asexual blood-stage growth of the mutants proceeded normally across three erythrocytic cycles. Using a parasite line in which ap2-g expression is tagged with green fluorescent protein, the researchers sorted individual trophozoites that had committed to sexual development from those that had not. The committed, AP2-G-positive parasites displayed significantly enriched H2Bub and H3K4me3 at the ap2-g upstream region compared with their AP2-G-negative siblings. The team also manipulated culture conditions known to influence sexual conversion, growing parasites under commitment-inducing conditions of high parasitemia with reduced albumin supplementation, and observed that these inducing conditions were accompanied by increased H2Bub enrichment at the ap2-g promoter, linking the epigenetic mark to the environmental cues that naturally trigger gametocyte production.

The implications for malaria control are considerable. Transmission-blocking interventions—drugs, vaccines or other strategies that prevent parasites from completing their development in the mosquito—remain a critical but underserved frontier in malaria elimination, because a treatment that kills asexual parasites while leaving gametocyte production intact can still leave the treated patient infectious to mosquitoes. By identifying the Rad6B–Tex1 ubiquitin ligase complex as the enzymatic gatekeeper of sexual commitment, the study supplies a pair of concrete molecular targets whose inhibition would suppress gametocyte formation at its epigenetic source. Because the pathway is conserved between rodent and human malaria parasites, the P. yoelii system can serve as a tractable model for screening inhibitors against the human equivalents. Beyond the translational angle, the work adds malaria parasites to the growing list of eukaryotes in which the ancient Rad6–Bre1 module of H2B monoubiquitination, first described in yeast more than two decades ago, serves as a master regulator of cell differentiation—here repurposed by a single-celled pathogen to choreograph one of the most consequential decisions in its life cycle, and in doing so, to choreograph the spread of a disease that still claims hundreds of thousands of lives each year.

Subject of Research: Epigenetic control of sexual commitment in malaria parasites via histone H2B monoubiquitination

Article Title: Histone H2B monoubiquitination drives sexual commitment in malaria parasites

Article References: Jiao, Z., Lin, L., Tang, R., Zhong, C.-Q., Wu, C., Li, W., Xu, R., Gao, Y., He, P., Wang, C., Zhang, Q.-Q., Liu, S., Yuan, J., Zhang, Q., & Li, J. (2026). Histone H2B monoubiquitination drives sexual commitment in malaria parasites. Nature Microbiology. https://doi.org/10.1038/s41564-026-02475-4

Image Credits: AI Generated

DOI: 10.1038/s41564-026-02475-4

Keywords: malaria, Plasmodium, gametocytogenesis, histone H2B monoubiquitination, Rad6B, Tex1, AP2-G, epigenetics, ubiquitin ligase, H3K4me3, sexual commitment, transmission blocking